Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03829410
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2019-02-01
Brief Title:
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation
Sponsor:
Cardiff Oncology
Organization:
Cardiff Oncology